TTOO logo

T2 Biosystems (TTOO) EBITDA

Annual EBITDA

-$43.88 M
+$11.00 M+20.04%

December 31, 2023

Summary

Performance

1-Year Change

+20.04%

3-Year Change

-15.08%

5-Year Change

-4.41%

15-Year Change

+13.26%

TTOO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.56%
TTOO annual EBITDA is higher than 35.56% of companies in Healthcare sector

High & Low

All-time High

-$13.73 M

3-Year Low

-$54.87 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
TTOO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 14, 2025
TTOO next annual earnings announcement is scheduled for Feb 14, 2025

OtherTTOOprofitabilitymetrics:

Annual Revenue

$7.19 M
TTOO annual revenue is $7.19 million

Annual Net Income

-$50.08 M
TTOO annual net profit is -$50.08 million

Annual EBIT

-$44.73 M
TTOO annual earnings before interest & taxes is -$44.73 million

Annual EPS

-$19.19
TTOO annual earnings per share is -$19.19

Quarterly EBITDA

-$9.69 M
-$1.26 M-15.02%

September 30, 2024

Summary

Performance

3-Month Change

-15.02%

1-Year Change

-6.4%

3-Year Change

+15.46%

5-Year Change

+9.53%

TTOO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.61%
TTOO quarterly EBITDA is higher than 36.61% of companies in Healthcare sector

High & Low

All-time High

-$4.34 M

3-Year Low

-$16.44 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TTOO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
TTOO next earnings announcement is scheduled for Feb 14, 2025

OtherTTOOprofitabilitymetrics:

Quarterly Revenue

$1.99 M
TTOO quarterly revenue is $1.99 million

Quarterly Net Income

-$10.12 M
TTOO quarterly net profit is -$10.12 million

Quarterly EBIT

-$9.75 M
TTOO quarterly earnings before interest & taxes is -$9.75 million

Quarterly EPS

-$0.57
TTOO quarterly earnings per share is -$0.57

TTM EBITDA

-$39.51 M
+$4.36 M+9.93%

September 30, 2024

Summary

Performance

3-Month Change

+9.93%

1-Year Change

+9.96%

3-Year Change

-4.19%

5-Year Change

+17.72%

TTOO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.02%
TTOO TTM EBITDA is higher than 36.02% of companies in Healthcare sector

High & Low

All-time High

-$4.34 M

3-Year Low

-$56.50 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TTOO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
TTOO next earnings announcement is scheduled for Feb 14, 2025

OtherTTOOprofitabilitymetrics:

TTM Revenue

$7.68 M
TTOO TTM revenue is $7.68 million

TTM Net Income

-$42.95 M
TTOO TTM net profit is -$42.95 million

TTM EBIT

-$39.77 M
TTOO TTM earnings before interest & taxes is -$39.77 million

TTM EPS

-$6.42
TTOO TTM earnings per share is -$6.42

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$43.88 M
TTOO annual EBITDA is -$43.88 million

Annual Net Income

-$50.08 M
TTOO annual net profit is -$50.08 million

Annual Interest Expense

$5.34 M
TTOO annual interest expense is $5.34 million

Annual Income Tax

-
TTOO annual income tax value is unknown

Annual D&A

$859.00 K
TTOO annual depreciation & amortization is $859.00 thousand

TTOO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.0%-6.4%+10.0%
3 y3 years-15.1%+15.5%-4.2%
5 y5 years-4.4%+9.5%+17.7%

TTOO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-12.2%+20.0%-113.4%+41.1%at high+30.1%
5 y5-year-15.1%+20.0%-113.4%+41.1%-15.1%+30.1%
alltimeall time-219.6%+20.0%-123.4%+41.1%-810.9%+30.1%

T2 Biosystems EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9.69 M(+15.0%)
-$39.51 M(-9.9%)
Jun 2024
-
-$8.42 M(-31.5%)
-$43.86 M(+9.7%)
Mar 2024
-
-$12.29 M(+35.0%)
-$39.98 M(-8.9%)
Dec 2023
-$43.88 M(-20.0%)
-$9.11 M(-35.2%)
-$43.88 M(+1.8%)
Sep 2023
-
-$14.04 M(+209.4%)
-$43.09 M(-3.4%)
Jun 2023
-
-$4.54 M(-72.0%)
-$44.60 M(-21.1%)
Mar 2023
-
-$16.19 M(+94.6%)
-$56.50 M(+3.0%)
Dec 2022
-$54.87 M(+40.3%)
-$8.32 M(-46.5%)
-$54.87 M(-2.3%)
Sep 2022
-
-$15.55 M(-5.4%)
-$56.19 M(+7.9%)
Jun 2022
-
-$16.44 M(+12.9%)
-$52.09 M(+14.1%)
Mar 2022
-
-$14.56 M(+51.1%)
-$45.66 M(+14.3%)
Dec 2021
-$39.11 M(+2.6%)
-$9.63 M(-15.9%)
-$39.94 M(+5.3%)
Sep 2021
-
-$11.46 M(+14.5%)
-$37.92 M(+4.5%)
Jun 2021
-
-$10.01 M(+13.3%)
-$36.30 M(+5.8%)
Mar 2021
-
-$8.84 M(+16.0%)
-$34.33 M(-10.0%)
Dec 2020
-$38.12 M(-20.6%)
-$7.62 M(-22.6%)
-$38.12 M(-9.2%)
Sep 2020
-
-$9.84 M(+22.6%)
-$41.98 M(-2.0%)
Jun 2020
-
-$8.03 M(-36.4%)
-$42.84 M(-11.1%)
Mar 2020
-
-$12.63 M(+10.2%)
-$48.18 M(+0.4%)
Dec 2019
-$48.02 M(+14.3%)
-$11.47 M(+7.1%)
-$48.02 M(-2.7%)
Sep 2019
-
-$10.71 M(-19.9%)
-$49.34 M(+5.1%)
Jun 2019
-
-$13.37 M(+7.3%)
-$46.92 M(+7.2%)
Mar 2019
-
-$12.47 M(-2.5%)
-$43.77 M(+4.2%)
Dec 2018
-$42.02 M
-$12.79 M(+54.2%)
-$42.02 M(-1.8%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$8.29 M(-18.9%)
-$42.78 M(-7.2%)
Jun 2018
-
-$10.22 M(-4.6%)
-$46.08 M(-5.8%)
Mar 2018
-
-$10.72 M(-20.9%)
-$48.92 M(-3.3%)
Dec 2017
-$50.58 M(+4.5%)
-$13.55 M(+16.8%)
-$50.58 M(+2.7%)
Sep 2017
-
-$11.60 M(-11.2%)
-$49.24 M(+0.5%)
Jun 2017
-
-$13.06 M(+5.6%)
-$49.00 M(+0.7%)
Mar 2017
-
-$12.37 M(+1.3%)
-$48.64 M(+0.4%)
Dec 2016
-$48.43 M(+15.7%)
-$12.21 M(+7.6%)
-$48.43 M(+2.5%)
Sep 2016
-
-$11.35 M(-10.7%)
-$47.25 M(+1.3%)
Jun 2016
-
-$12.70 M(+4.4%)
-$46.66 M(+5.7%)
Mar 2016
-
-$12.16 M(+10.2%)
-$44.13 M(+5.4%)
Dec 2015
-$41.86 M(+39.6%)
-$11.03 M(+2.5%)
-$41.86 M(+6.2%)
Sep 2015
-
-$10.76 M(+5.8%)
-$39.42 M(+8.6%)
Jun 2015
-
-$10.17 M(+2.9%)
-$36.28 M(+9.4%)
Mar 2015
-
-$9.89 M(+15.1%)
-$33.18 M(+10.7%)
Dec 2014
-$29.98 M(+52.8%)
-$8.59 M(+12.7%)
-$29.98 M(+8.9%)
Sep 2014
-
-$7.63 M(+7.9%)
-$27.52 M(+13.3%)
Jun 2014
-
-$7.07 M(+5.7%)
-$24.28 M(+10.5%)
Mar 2014
-
-$6.69 M(+9.1%)
-$21.98 M(+12.0%)
Dec 2013
-$19.62 M(+42.9%)
-$6.13 M(+39.8%)
-$19.62 M(+45.5%)
Sep 2013
-
-$4.39 M(-7.9%)
-$13.49 M(+48.2%)
Jun 2013
-
-$4.76 M(+9.8%)
-$9.10 M(+109.8%)
Mar 2013
-
-$4.34 M
-$4.34 M
Dec 2012
-$13.73 M
-
-

FAQ

  • What is T2 Biosystems annual EBITDA?
  • What is the all time high annual EBITDA for T2 Biosystems?
  • What is T2 Biosystems annual EBITDA year-on-year change?
  • What is T2 Biosystems quarterly EBITDA?
  • What is the all time high quarterly EBITDA for T2 Biosystems?
  • What is T2 Biosystems quarterly EBITDA year-on-year change?
  • What is T2 Biosystems TTM EBITDA?
  • What is the all time high TTM EBITDA for T2 Biosystems?
  • What is T2 Biosystems TTM EBITDA year-on-year change?

What is T2 Biosystems annual EBITDA?

The current annual EBITDA of TTOO is -$43.88 M

What is the all time high annual EBITDA for T2 Biosystems?

T2 Biosystems all-time high annual EBITDA is -$13.73 M

What is T2 Biosystems annual EBITDA year-on-year change?

Over the past year, TTOO annual EBITDA has changed by +$11.00 M (+20.04%)

What is T2 Biosystems quarterly EBITDA?

The current quarterly EBITDA of TTOO is -$9.69 M

What is the all time high quarterly EBITDA for T2 Biosystems?

T2 Biosystems all-time high quarterly EBITDA is -$4.34 M

What is T2 Biosystems quarterly EBITDA year-on-year change?

Over the past year, TTOO quarterly EBITDA has changed by -$583.00 K (-6.40%)

What is T2 Biosystems TTM EBITDA?

The current TTM EBITDA of TTOO is -$39.51 M

What is the all time high TTM EBITDA for T2 Biosystems?

T2 Biosystems all-time high TTM EBITDA is -$4.34 M

What is T2 Biosystems TTM EBITDA year-on-year change?

Over the past year, TTOO TTM EBITDA has changed by +$4.37 M (+9.96%)